Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,837,566
in 4 filings, $626K under 10b5-1 plans

Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 78 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-05-22 Demopulos Peter A MD Director Grant or award · Stock Option (right to buy) +5,000 5,000
2015-05-22 HANISH ARNOLD C Director Grant or award · Stock Option (right to buy) +5,000 5,000
2015-05-22 Aspiri Ray Director Grant or award · Stock Option (right to buy) +5,000 5,000
2015-05-22 Cable Thomas J. Director Grant or award · Stock Option (right to buy) +5,000 5,000
2015-05-22 Hood Leroy E. MD PhD Director Grant or award · Stock Option (right to buy) +5,000 5,000
2015-03-24 Cable Thomas J. Director Sale −1,790 $24.43 $44K 55,277
2015-03-24 Cable Thomas J. Director Sale −210 $25.07 $5K 55,067
2015-01-28 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +32,000 $0.98 $31K 1,591,822
2015-01-28 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −32,000 293,163
2014-11-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +33,000 $0.98 $32K 1,559,822
2014-11-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −33,000 325,163

Page 20 of 20 · 391 trades